Connect with us

Medical Research

Final CBD Clinical Study Results Published by Lexaria of Its DehydraTECH-Powered TurboCBD

Dr Kristie Leong

Published

on

Final CBD Clinical Study Results Published by Lexaria of Its DehydraTECH-Powered TurboCBD
- Ad -
  • Lexaria is a global innovator in drug delivery platforms.
  • Their recent human clinical study on CBD delivery was published in “Advances in Therapy.”

As the world works to understand everything that CBD can potentially do, Lexaria Bioscience Corp (“Lexaria”) set up a human clinical study last year to find out for itself.

The study sought answers regarding CBD delivery and effectiveness, based on the patented DehydraTECH powered TurboCBD capsules. This global innovator on drug delivery announced via ACCESSWIRE that the results of this study have been published in “Advances in Therapy,” a peer-reviewed medical journal. Advances in Therapy has continually focused on clinical and pharmaceutical research for over 30 years.

In the results, there were a few key findings that ACCESSWIRE shed light on.

  • The in-plasma levels of CBD with the use of the 90 mg TurboCBD dose were higher than with a generic dose, recorded at both 90-minute and 120-minute intervals.
  • At the 30-minute mark, the 90 mg dose became elevated, and it remained elevated through the 4-hour mark.
  • Participants experienced a decreased mean arterial blood pressure (MAP) with the use of the 90 mg dose.
  • Cerebral perfusion in the middle cerebral artery was higher with the 90 mg TurboCBD dose.

The study involved 12 young and healthy male athletes, finding that capsules to be well-tolerated, but that additional studies were necessary for any conclusive evidence. More specifically, the report on this study noted that performing additional studies involving “acute and chronic dosing investigations in older and cerebrovascular-compromised patients” could help with understanding the impact of CBD bioavailability.

Lexaria was recently provided with two patents, meant for treating heart disease, neurological diseases, and other conditions, coinciding with the demonstration of how effective the DehydraTECH technology is in the increase of cerebral blood flow.

Consumers can view the peer-reviewed study at either http://pr.report/Er9Jmgt8 or http://pr.report/KZ8lLWvt.

Kristie Leong M.D. is a family physician with a strong interest in nutrition and fitness and the role each places in wellness and longevity. Dr. Leong graduated in 1990 from Virginia Commonwealth University School of Medicine with a medical degree and master’s degree in clinical pathology. After 20 years of caring for patients in a family practice setting, Dr. Leong redirected her energy towards exploring the role nutrition and lifestyle play in lifespan and, more importantly, health span, the number of years we spend disease free and healthy enough to enjoy life. Through continuing medical education courses, seminars, and other self-study, she delved into the critical role diet and lifestyle choices play in health, especially as we age.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com